PUBLISHER: The Business Research Company | PRODUCT CODE: 2132120
PUBLISHER: The Business Research Company | PRODUCT CODE: 2132120
Ribonucleic acid (RNA) cleanup refers to laboratory-based processes designed to purify RNA molecules by removing contaminants such as proteins, genomic DNA, salts, enzymes, and other cellular impurities. It is an essential step in molecular biology workflows to ensure that RNA samples possess sufficient quality and integrity for downstream analytical and research applications, including sequencing, gene expression profiling, and molecular diagnostics. These processes utilize controlled biochemical methods and laboratory techniques to preserve RNA stability and prevent degradation.
The primary product types of ribonucleic acid (RNA) cleanup include magnetic beads, spin columns, filter plates, ribonucleic acid cleanup kits, and reagents and consumables. Magnetic beads are microscopic particles coated with specific materials that bind and purify RNA molecules efficiently by using magnetic separation methods, enabling high-quality RNA recovery for molecular analysis. These products are available in small volume (50 milliliters), medium volume (50 to 100 milliliters), and large volume (above 100 milliliters) formats and are used with sample types including blood, tissue, cells, saliva, and plant samples. The various applications involved are research, clinical diagnostics, infectious disease testing, oncology, and drug development, and they are used by several end uses such as hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies, and others.
Tariffs are influencing the ribonucleic acid (RNA) cleanup market by increasing the cost of imported laboratory reagents, magnetic beads, spin columns, filter plates, and specialized consumables required for RNA purification workflows. This is affecting product segments such as RNA cleanup kits, reagents, and high throughput purification components, with regions including North America, Europe, and Asia-Pacific experiencing supply chain and pricing challenges due to reliance on global suppliers. Consumable-intensive segments are more affected because of continuous demand for imported raw materials and specialized manufacturing processes. However, tariffs are encouraging local production, regional sourcing strategies, and investments in domestic biotechnology manufacturing capabilities, improving long-term supply chain stability.
The ribonucleic acid (rna) cleanup market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) cleanup market statistics, including ribonucleic acid (rna) cleanup industry global market size, regional shares, competitors with a ribonucleic acid (rna) cleanup market share, detailed ribonucleic acid (rna) cleanup market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) cleanup industry. This ribonucleic acid (rna) cleanup market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (RNA) cleanup market size has grown rapidly in recent years. It will grow from $1.6 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the increasing demand for molecular biology research, the rising adoption of RNA sequencing technologies, the growing need for high-quality nucleic acid samples, the expanding infectious disease testing applications, and the increasing biotechnology and pharmaceutical research activities.
The ribonucleic acid (RNA) cleanup market size is expected to see strong growth in the next few years. It will grow to $2.56 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine applications, rising adoption of automated laboratory workflows, growing research activities in transcriptomics and genomic analysis, expanding clinical diagnostic applications, and increasing investments in life science research infrastructure. Major trends in the forecast period include growing adoption of high-purity RNA cleanup workflows for advanced molecular analysis, increasing development of automated RNA purification systems for improved laboratory efficiency, rising demand for contamination-free RNA sample preparation methods, expanding use of RNA cleanup processes in sequencing and gene expression studies, and increasing availability of specialized RNA cleanup kits for diverse sample types.
The increasing adoption of precision medicine is expected to propel the growth of the ribonucleic acid (RNA) cleanup market in the forecast period. Precision medicine refers to a healthcare approach that customizes treatment strategies based on individual patient characteristics, including genetic profiles, biomarkers, and disease phenotypes. The adoption of precision medicine is expanding due to advancements in biomarker discovery and molecular diagnostics, which enable more accurate identification and classification of respiratory and other complex conditions, supporting the selection of targeted therapies. Ribonucleic acid (RNA) cleanup supports precision medicine by ensuring the availability of high-quality, contaminant-free RNA for accurate gene expression analysis and molecular research, enabling clinicians and researchers to identify patient-specific biomarkers, develop targeted treatment approaches, and make more precise diagnostic and therapeutic decisions based on genetic information. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) authorized 16 new personalized therapies for patients with rare diseases in 2023, representing a significant increase compared with the six approvals recorded in 2022. Therefore, the increasing adoption of precision medicine is driving the growth of the ribonucleic acid (RNA) cleanup market.
Companies operating in the ribonucleic acid (RNA) cleanup market are focusing on developing innovative solutions, such as advanced RNA cleanup technologies, to address the rising demand for high-purity RNA isolation, next-generation sequencing preparation, and precision molecular research applications. These technologies utilize magnetic bead-based purification, automated cleanup workflows, and high-sensitivity nucleic acid processing methods to enhance RNA recovery efficiency and contaminant removal compared with traditional column-based purification techniques. In March 2024, New England Biolabs, a US-based biotechnology company, launched the Monarch Mag Viral DNA/RNA Extraction Kit, an innovative RNA cleanup and purification solution associated with this market. The platform utilizes magnetic bead-based technology to enable rapid and efficient RNA cleanup, inhibitor removal, and high-quality nucleic acid extraction for molecular diagnostics and sequencing workflows. It also provides automation compatibility, scalable sample processing, and enhanced RNA purity for advanced genomics and life sciences research applications.
In April 2023, MolGen B.V., a Netherlands-based biotechnology and life sciences technology company, acquired Synchron Instrumenten B.V. for an undisclosed amount. Through this acquisition, MolGen aimed to strengthen and broaden its laboratory automation capabilities by integrating Synchron's custom liquid handling systems and robotic automation technologies with its DNA/RNA extraction and reagent portfolio, thereby enhancing its ability to provide end-to-end high-throughput workflows for genomics and molecular diagnostics applications. Synchron Instrumenten B.V. is a Netherlands-based laboratory automation company that specializes in providing systems designed to support RNA cleanup.
Major companies operating in the ribonucleic acid (rna) cleanup market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Creative Diagnostics Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Geneaid Biotech Ltd., Macherey-Nagel GmbH & Co. KG, Merck KGaA, Miltenyi Biotec B.V., New England Biolabs Inc., Norgen Biotek Corp., Omega Bio-tek Inc., Promega Corporation, QIAGEN N.V., RayBiotech Inc., Revvity Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Zymo Research Corporation
North America was the dominating region in the ribonucleic acid (RNA) cleanup market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) cleanup market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) cleanup market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic Acid (RNA) cleanup market consists of sales of RNA purification systems, enzymatic RNA treatment solutions, nucleic acid purification platforms, laboratory extraction and cleanup instruments, and automated purification workstations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Cleanup Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid (rna) cleanup market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ribonucleic acid (rna) cleanup ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) cleanup market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.